CONMED (CNMD) Stock Forecast & Price Target

CNMD price $45.55 -0.21 -0.47%

Ticker
CNMD
Price
$45.55
Change
-0.21 -0.47%
Market cap ?
$1.36B
P/E ?
26.59
Forward P/E ?
10.04
Dividend yield ?
0.00%
Beta ?
0.94
Sector
Healthcare
Industry
Medical - Devices

Financials

2016201720182019202020212022202320242025
76352000079639200085963400095509700086245900010106350001045472000124474400013070150001374495000

CONMED Corporation functions as a medical technology enterprise, specializing in the global development, production, and distribution of surgical instruments and related apparatus for a variety of surgical procedures. Its comprehensive product portfolio includes specialized orthopedic surgical items, such as the TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-Knot All-Suture Anchors, and PopLok…

Fair value

CNMD fair value $105.53. Price $45.55. Price is 57% below fair value.

Below fair value, and cheaper than usual. A larger discount than on 83% of days in the past 5 years.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 132.69M. Growth 4.29%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 9.48% (beta 0.9). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 29.95M. Net debt 794.12M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Compare CNMD

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2027-02-03—1.26—366.95M
2026-10-281.041.00335.56M336.28M
2026-07-291.381.11343.49M337.60M
2026-04-290.890.82317.05M310.64M
2026-01-281.431.32373.20M366.88M
2025-11-051.081.05337.93M366.88M
2025-07-301.151.13342.35M334.60M
2025-04-300.950.81321.26M313.38M
2025-02-051.341.20347.93M341.05M
2024-10-301.050.99316.70M318.13M
2024-07-310.980.91330.75M332.32M
2024-04-240.790.74311.63M306.78M
2024-01-311.061.11327.05M332.20M
2023-10-250.900.83304.58M300.91M
2023-07-260.830.79317.65M306.09M
2023-04-260.660.60295.47M266.67M
2023-02-020.420.93250.87M302.48M
2022-10-260.770.75275.09M280.83M
2022-07-270.760.76277.19M275.75M
2022-05-040.700.62242.33M235.77M
2022-01-261.071.03273.97M275.82M
2021-10-270.800.77248.83M256.26M
2021-07-280.710.62255.16M248.50M
2021-04-280.630.43232.68M216.88M
2021-01-270.840.76252.83M262.94M
2020-10-280.880.25237.84M62.16K
2020-07-29-0.07-1.02157.78M2.14B
2020-04-290.510.44214.01M193.03M
2020-01-290.900.89264.87M261.92M
2019-10-300.620.56233.59M210.98M
2019-07-310.560.53238.26M225.50M
2019-04-240.570.54218.38M206.88M
2019-01-220.730.73242.44M239.08M
2018-11-010.460.45202.31M202.30M
2018-08-010.460.45212.82M208.17M
2018-04-250.530.43202.06M167.78M
2018-01-310.690.65222.56M209.70M
2017-11-020.420.41190.12M185.57M
2017-07-260.410.41197.15M197.20M
2017-04-260.380.34186.57M171.87M

Dividends

Yield 0.00%. Payout ratio 8.43%. Frequency Quarterly.

Safety score 62/100 · Moderate. Payout ratio is 8% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. Dividends were paid in 14 separate years. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
2025-09-15$0.202025-09-152025-10-03Quarterly
2025-06-13$0.202025-06-132025-07-03Quarterly
2025-03-14$0.202025-03-142025-04-04Quarterly
2024-12-20$0.202024-12-202025-01-03Quarterly
2024-09-16$0.202024-09-162024-10-04Quarterly
2024-06-14$0.202024-06-142024-07-05Quarterly
2024-03-14$0.202024-03-152024-04-05Quarterly
2023-12-15$0.202023-12-182024-01-05Quarterly
2023-09-14$0.202023-09-152023-10-05Quarterly
2023-06-14$0.202023-06-152023-07-05Quarterly
2023-03-14$0.202023-03-152023-04-05Quarterly
2022-12-15$0.202022-12-162023-01-05Quarterly
2022-09-14$0.202022-09-152022-10-05Quarterly
2022-06-14$0.202022-06-152022-07-05Quarterly
2022-03-14$0.202022-03-152022-04-05Quarterly
2021-12-14$0.202021-12-152022-01-05Quarterly
2021-09-14$0.202021-09-152021-10-05Quarterly
2021-06-14$0.202021-06-152021-07-06Quarterly
2021-03-12$0.202021-03-152021-04-05Quarterly
2020-12-14$0.202020-12-152021-01-05Quarterly
2020-09-14$0.202020-09-152020-10-05Quarterly
2020-06-12$0.202020-06-152020-07-06Quarterly
2020-03-13$0.202020-03-162020-04-06Quarterly
2019-12-12$0.202019-12-132020-01-07Quarterly
2019-09-12$0.202019-09-132019-10-07Quarterly
2019-06-13$0.202019-06-142019-07-05Quarterly
2019-03-14$0.202019-03-152019-04-05Quarterly
2018-12-13$0.202018-12-142019-01-07Quarterly
2018-09-13$0.202018-09-142018-10-08Quarterly
2018-06-14$0.202018-06-152018-07-05Quarterly
2018-03-14$0.202018-03-152018-04-05Quarterly
2017-12-14$0.202017-12-152018-01-05Quarterly
2017-09-14$0.202017-09-152017-10-05Quarterly
2017-06-13$0.202017-06-152017-07-05Quarterly
2017-03-13$0.202017-03-152017-04-05Quarterly
2016-12-13$0.202016-12-152017-01-05Quarterly
2016-09-13$0.202016-09-152016-10-05Quarterly
2016-06-13$0.202016-06-152016-07-06Quarterly
2016-03-11$0.202016-03-152016-04-05Quarterly
2015-12-11$0.202015-12-152016-01-05Quarterly
2015-09-11$0.202015-09-152015-10-05Quarterly
2015-06-11$0.202015-06-152015-07-06Quarterly
2015-03-12$0.202015-03-162015-04-06Quarterly
2014-12-11$0.202014-12-152015-01-05Quarterly
2014-09-11$0.202014-09-152014-10-06Quarterly
2014-06-12$0.202014-06-162014-07-07Quarterly
2014-03-13$0.202014-03-172014-04-07Quarterly
2013-12-12$0.202013-12-162014-01-06Quarterly
2013-09-12$0.152013-09-162013-10-04Quarterly
2013-06-13$0.152013-06-172013-07-08Quarterly
2013-03-13$0.152013-03-152013-04-05Quarterly
2012-12-13$0.152012-12-172013-01-07Quarterly
2012-09-12$0.152012-09-142012-10-05Quarterly
2012-06-13$0.152012-06-152012-07-06Quarterly
2012-03-13$0.152012-03-152012-04-05Quarterly

Insider trades

DateInsiderActionSharesPriceValue
2026-09-08Kelderman KimBuy500——
2026-09-08Kelderman KimSell500——
2026-07-15Gallagher John EBuy26.88K——
2026-07-15Gallagher John EBuy35.05K——
2026-07-15Gallagher John EBuy30.54K$42.791.31M
2026-07-15Gallagher John EOther0——
2026-07-01Martin Celine ChristineBuy5.60K——
2026-07-01Mirviss Jeffrey B.Buy5.60K——
2026-07-01Mirviss Jeffrey B.Other0——
2026-07-01Martin Celine ChristineOther0——
2026-06-01Lockwood KimberlyOther0——
2026-06-01Lockwood KimberlyOther2.50K$96.16240.40K
2026-06-01Lockwood KimberlyOther1.40K$59.9683.94K
2026-06-01Lockwood KimberlyOther3.20K$78.76252.03K
2026-06-01Lockwood KimberlyOther3.50K$97.69341.92K
2026-06-01Lockwood KimberlyOther3.50K$122.55428.93K
2026-06-01Lockwood KimberlyOther2.75K$144.55397.51K
2026-06-01Lockwood KimberlyOther2.50K$79.95199.88K
2026-06-01Lockwood KimberlyOther4.50K$58.33262.49K
2026-06-01Lockwood KimberlyOther2.84K——
2026-04-01Beyer PatBuy28.14K——
2026-03-06Lalomia BrentBuy75——
2026-03-06Lalomia BrentSell26$39.901.04K
2026-03-06Lalomia BrentSell75——
2026-03-02Lalomia BrentBuy17.20K——
2026-03-02Schabacker MatthewBuy17.47K——
2026-03-02Foust Hollie KBuy18.56K——
2026-03-02Ferrell John D.Buy16.93K——
2026-03-02SHAGORY PETER KBuy16.93K——
2026-03-02Schabacker MatthewBuy11.65K$45.79533.27K
2026-03-02Schabacker MatthewBuy9.83K——
2026-03-02Ferrell John D.Buy11.00K$45.79503.64K
2026-03-02Ferrell John D.Buy9.28K——
2026-03-02Pelletier Johonna MarieBuy5.90K——
2026-03-02SHAGORY PETER KBuy11.00K$45.79503.64K
2026-03-02SHAGORY PETER KBuy9.28K——
2026-03-02Lalomia BrentBuy11.32K$45.79518.43K
2026-03-02Lalomia BrentBuy9.55K——
2026-03-02Foust Hollie KBuy12.94K$45.79592.52K
2026-03-02Foust Hollie KBuy10.92K——
2026-03-02Moller Andrew JamesBuy5.90K——
2026-03-02Beyer PatBuy68.26K$45.793.13M
2026-03-02Beyer PatBuy28.80K——
2026-02-24Kaye MarkBuy152——
2026-02-24Kaye MarkSell152——
2025-12-31Lalomia BrentBuy32$40.601.28K
2025-12-31Lalomia BrentOther0——
2025-11-21Glaze RichardSell257$41.2110.59K
2025-11-20Glaze RichardSell375——
2025-11-20Glaze RichardBuy375——
2025-11-20Glaze RichardSell118$40.634.79K
2025-11-06Garner Todd WSell3.50K$43.00150.50K
2025-11-04Foust Hollie KSell4.00K——
2025-11-04Foust Hollie KBuy4.00K——
2025-11-04Foust Hollie KSell1.11K$45.7150.92K
2025-10-31Garner Todd WSell7.50K——
2025-10-31Garner Todd WBuy7.50K——
2025-10-31Garner Todd WSell2.16K$44.0095.22K
2025-09-12Farkas CharlesSell1.10K$53.5359.05K
2025-09-12Farkas CharlesSell897$53.5148.00K
2025-09-08Kelderman KimBuy6.23K$53.83335.20K
2025-09-08Kelderman KimBuy500——
2025-09-08Kelderman KimOther0——
2025-08-07Garner Todd WSell598$52.4531.37K
2025-06-03Schwarzentraub Barbara JBuy479——
2025-06-03Schwarzentraub Barbara JSell479——
2025-06-03Concannon BrianBuy479——
2025-06-03Concannon BrianSell479——
2025-06-03Farkas CharlesBuy479——
2025-06-03Farkas CharlesSell479——
2025-06-03Council LaVerne HBuy479——
2025-06-03Council LaVerne HSell479——
2025-06-03Bronson David M.Buy479——
2025-06-03Bronson David M.Sell479——
2025-06-03Aronson Martha GoldbergBuy479——
2025-06-03Aronson Martha GoldbergSell479——
2025-06-02Schwarzentraub Barbara JBuy8.06K$55.38446.42K
2025-06-02Schwarzentraub Barbara JBuy668——
2025-06-02Kaye MarkBuy8.06K$55.38446.42K
2025-06-02Kaye MarkBuy668——
2025-06-02Concannon BrianBuy8.06K$55.38446.42K
2025-06-02Concannon BrianBuy668——
2025-06-02Farkas CharlesBuy8.06K$55.38446.42K
2025-06-02Farkas CharlesBuy668——
2025-06-02Council LaVerne HBuy8.06K$55.38446.42K
2025-06-02Council LaVerne HBuy668——
2025-06-02Bronson David M.Buy8.06K$55.38446.42K
2025-06-02Bronson David M.Buy668——
2025-06-02Aronson Martha GoldbergBuy8.06K$55.38446.42K
2025-06-02Aronson Martha GoldbergBuy668——
2025-05-29Farkas CharlesBuy1.00K$55.7055.70K
2025-05-29Farkas CharlesSell966$57.6955.73K
2025-05-29Farkas CharlesSell1.00K$55.7055.70K
2025-05-20Workman John LBuy479$59.8428.66K
2025-05-20Workman John LSell479——
2025-05-05Farkas CharlesSell4.00K$56.94227.77K
2025-04-28Schabacker MatthewOther0——
2025-04-28Schabacker MatthewBuy31.68K$50.841.61M
2025-03-31Garner Todd WBuy371$57.3721.28K
2025-03-14SHAGORY PETER KBuy4.50K$55.42249.39K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 251, holders +11 vs prior quarter. Ownership 113.02%.

HolderSharesChangeChange %Value
BLACKROCK, INC.4.82M-4.43K-0.09%157.78M
EARNEST PARTNERS LLC2.51M-64.36K-2.50%82.00M
VANGUARD PORTFOLIO MANAGEMENT LLC2.19M112.34K+5.41%71.64M
FULLER & THALER ASSET MANAGEMENT, INC.1.58M-61.85K-3.77%51.71M
STATE STREET CORP1.42M33.45K+2.42%46.39M
VANGUARD CAPITAL MANAGEMENT LLC1.36M-28.31K-2.05%44.37M
BANK OF AMERICA CORP /DE/1.34M-61.21K-4.36%43.90M
DIMENSIONAL FUND ADVISORS LP1.32M-75.55K-5.42%43.12M
SEI INVESTMENTS CO988.15K-16.56K-1.65%32.34M
INVENOMIC CAPITAL MANAGEMENT LP842.16K-92.44K-9.89%27.56M
CAPITAL RESEARCH GLOBAL INVESTORS823.64K-101.81K-11.00%26.96M
GEODE CAPITAL MANAGEMENT, LLC790.14K47.53K+6.40%25.87M
TWO SIGMA INVESTMENTS, LP728.98K-53.56K-6.84%23.86M
ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC618.45K35.71K+6.13%20.26M
COOKE & BIELER LP573.50K-414.29K-41.94%18.77M
PARADIGM CAPITAL MANAGEMENT INC/NY538.25K538.25KNew17.62M
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP476.88K57.79K+13.79%15.61M
CHARLES SCHWAB INVESTMENT MANAGEMENT INC471.02K-7.58K-1.58%15.42M
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P.471.02K471.02KNew15.42M
SILVERCREST ASSET MANAGEMENT GROUP LLC441.36K-207.22K-31.95%14.45M
GOLDMAN SACHS GROUP INC436.83K-39.82K-8.35%14.30M
AMERIPRISE FINANCIAL INC436.29K-23.91K-5.19%14.28M
LSV ASSET MANAGEMENT402.40K402.40KNew13.17M
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC370.69K53.24K+16.77%12.13M
NORTHERN TRUST CORP351.36K17.01K+5.09%11.50M

Forecast

Consensus Hold from 21 analysts. Average price target $37.50, -17.7% versus the current price. Low $36.00. High $39.00.

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Analysts have an average 12-month price target of $37.50 for CONMED (CNMD), 17.3% below the current price of $45.36. Of 21 analysts covering the stock, 7 rate it Buy or Strong Buy, 13 Hold, and 1 Sell or Strong Sell, giving a consensus of Hold.

Forecasts are third-party estimates and often wrong. They are not investment advice.

CNMD price target

12-month price target
Low$36.00
Average$37.50
High$39.00

The average is 17.3% below the current price of $45.36.

Is CONMED a buy or sell?

Of 21 analysts, 7 rate CONMED Buy or Strong Buy, 13 Hold, and 1 Sell or Strong Sell. The consensus label is Hold. That split is not a recommendation.

CONMED earnings and revenue forecast

Analyst averages on file: 2026, EPS $4.54, revenue $1.37 billion. 2027, EPS $4.78, revenue $1.43 billion.

CNMD score and fair value

The Stocklytics Score, when it is published for CNMD, averages value, quality, and growth on a 0–100 scale. It is not a price target. Fair value is a separate estimate on the fair value tab.

CNMD forecast FAQs

What is the CNMD price target?

$37.50 average, with a published range of $36.00 to $39.00.

Is CONMED a buy or sell?

The consensus is Hold from 21 analysts. This is not a recommendation.

What is the CONMED stock forecast for 2026?

Analysts' average EPS estimate for 2026 on file is $4.54. The average revenue estimate is $1.37 billion.

What will CNMD be worth in 2030?

No reliable forecast exists that far out.

When is CONMED's next earnings report?

The next earnings date is shown on the stock page when a future report is on the calendar. This forecast does not invent a date.

Capital is at risk. Stocklytics is operated by Stocklytics Inc., a Marshall Islands company. It is not regulated by the FCA and does not give investment advice.

CONMED (CNMD) Stock Forecast & Price Target

CNMD$45.55-0.21 -0.47%

$1.36B

Market Cap

26.59

P/E

10.04

Forward P/E

—

Score

Price History